🧬 Which Psoriasis Patients May Be Eligible for Biologic Treatment?

Psoriasis can vary widely in severity and impact. While many individuals manage well with topical creams or light therapy, biologic treatments may be considered for certain patients when the disease is more significant or difficult to control.

Biologics are advanced therapies that target specific pathways in the immune system responsible for inflammation.

🔍 Patients who may be considered for biologics include:

📊 Moderate to Severe Psoriasis: When psoriasis affects a large area of the body or causes thick, persistent plaques that significantly impact daily life.

🧴 Inadequate Response to Topical Treatments: If creams and ointments are not providing sufficient or lasting relief.

💡 Limited Benefit from Phototherapy or Tablets: When conventional systemic treatments or light therapy are not effective, not tolerated, or not suitable.

🖐️ Psoriasis in Difficult-to-Treat Areas: Involvement of the scalp, palms, soles, nails, face, or genital areas can significantly affect quality of life.

🦴 Associated Joint Symptoms: People with psoriasis who also experience joint pain or stiffness may have psoriatic arthritis, where biologics can play an important role.

💡 Awareness Insight: Eligibility for biologic therapy is determined after careful medical evaluation. The goal is to achieve better disease control while improving long-term comfort and quality of life.